Association of refractory complex partial seizures with a polymorphism of ApoE genotype

Journal of Cellular and Molecular Medicine

Volumn 9, Issue 3, 2005, Pages 698-703

  Sporiš, Davor ^a,d   Sertic, Jadranka ^a   Henigsberg, Neven ^b   Mahovic, Darija ^a   Bogdanovic, Nenad ^c   Babic, Tomislav ^a  

^a KBC Zagreb   (Croatia)

^b Psychiatric Hospital Vrap e   (Croatia)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Geriatric Department ^*  (Croatia)

Author keywords

ApoE polymorphism; Complex partial seizures; Ischaemia reperfusion; Non responders; Pharmacotherapy; Refractory epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; APOLIPOPROTEIN E;

ARTICLE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MIDDLE AGED; PILOT STUDY; REFERENCE VALUE; TEMPORAL LOBE EPILEPSY;

ANTICONVULSANTS; APOLIPOPROTEINS E; EPILEPSY, COMPLEX PARTIAL; GENOTYPE; HUMANS; MIDDLE AGED; PILOT PROJECTS; POLYMORPHISM, GENETIC; REFERENCE VALUES;

EID: 27744594300     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2005.tb00500.x     Document Type: Article

References (29)

1. Meldrum BS. Anatomy, physiology, and pathology of epilepsy. Lancet 1990; 336: 231-4.
2. Cedazo-Minguez A, Cowburn RF. Apolipoprotein E: a major piece in the Alzheimer's disease puzzle. J Cell Mol Med. 2001; 5: 254-66.
3. Beffert U Danik M, Krzywkowski P, Ramassamy C, Berrada F, Poirier J. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease. Brain Res Rev. 1998; 27: 119-42.
4. Weisgraber KH, Mahley RW. Human apolipoprotein E: the Alzheimer, disease connection. FASEB J. 1996; 10: 1485-94.
5. Smith JD. Apolipoprotein E4: an allele associated with many diseases. Ann Med. 2000; 32: 118-27.
6. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3.
7. McCarron MO, DeLong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease. Neurology 1999; 53: 1308-11.
8. Alberts MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter W, Saunders AM, Roses AD. ApoE genotype and survival from intracerebral haemorrhage (letter). Lancet 1995; 346: 575.
9. Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M, Tsenter J, Babaey S, Yehuda B, Groswasser Z. Apolipoproteine Eε4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 1999; 52: 244-8.
10. Chapman J, Vinokurov S, Achiron A, Karussis DM, Mitosek-Szewczyk K, Birnbaum M, Michaelson DM, Korczyn AD. APOE genotype is a major predictor of long-term progression of disability in MS. Neurology 2001; 56: 312-6.
11. Montpied P, de Bock F, Lerner-Natoli M, Bockaert J, Rondouin G. Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity. Epilepsy Res. 1999; 35: 135-46.
12. Taylor WJ, Diers MH. A Textbook for clinical application of therapeutic drug monitoring, Abbott Laboratories Diagnostics Irving, Texas. 1986.
13. Oertel R, Richter K, Gramatte T, Kirch W. Determination of drugs in biological fluids by high-perfomance liquid chromatography with on-line sample processing. J Chromatog A. 1998; 797: 203-9.
14. Hixson JE, Borenstein L, Cox LA, Rainwater DL, VanderBerg JL. The baboon gene for apolipoprotein A-I: characterization of a cDNA clone and identification of DNA polymorphisms for genetic studies of cholesterol metabolism. Gene 1988; 74: 483-490.
15. Hixon JE, Wernier DT. Restriction isotyping of human apolipoprotein E by gene aplification and cleavage with Hha1. J Lipid Res. 1990; 31: 545-8.
16. Buttini M, Akeefe H, Lin C, Mahley RW, Pitas RE, Wyss-Coray T, Mucke L. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience 2000; 97: 207-10.
17. 2+ and mitochondria as substrates for deficits in synaptic plasticity in normal brain ageing. J Cell Mol Med. 2004; 8: 181-90.
18. 2+ homeostasis and neuronal death. J Cell Mol Med. 2003; 7: 351-61.
19. Casetta I, Granieri E, Monneti VC, Gilli G, Tola MR, Paolino E, Govoni V, Iezzi E. Early predictors of intractability in childhood epilepsy: a community-based case-control study in Copparo, Italy. Acta Neurol Scan. 1999; 99: 329-33.
20. Gelisse P, Genton P, Thomas P, Rey M, Samuelian JC, Dravet C. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry. 2001; 70: 240-3.
21. MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JW, Shorvon SD. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol. 2000; 48: 833-41.
22. Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, Wood NW, Sisodiya SM. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med. 2003; 348: 1442-8.
23. Kilpatric ES, Jagger CE, Spooner RJ, Brodie MJ. Apolipoprotein E and epilepsy. Ann Clin Biochem. 1996; 33: 146-7.
24. Gambardella A, Aguglia U, Cittadella R, Romeo N, Sibilia G, LePiane E, Messina D, Manna I, Oliveri RL, Zappia M, Quattrone A. Apolipoprotein E polymorphisms and the risk of nonlesional temporal lobe epilepsy. Epilepsia 1999; 40: 1804-7.
25. Yeni SN, Ozkara C, Buyru N, Baykara O, Hanoglu L, Karaagac N, Ozyurt E, Uzan M. Association between APOE polymorphism and mesial temporal lobe epilepsy with hippocampal sclerosis. Eur J Neurol. 2005; 12: 103-7.
26. Diaz-Arrastia R, Gong Y, Fair S, Scott KD, Garcia MC, Carlile MC, Agostini MA, Van Ness PC. Increased risk of late postraumatic seizures associated with inheritance of APOEε4 allele. Arch Neurol. 2003; 60: 818-22.
27. Briellmann RS, Torn-Broers Y, Busuttil BE, Major BJ, Kalnins RM, Olsen M, Jackson GD, Frauman AG, Berkovic SF. APOEε4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology 2000; 55: 435-7.
28. Gouras GK, Relkin NR, Sweeney D, Munoz DG, Mackenzie IR, Gandy S. Increased apolipoprotein Eε4 in epilepsy with senile plaques. Ann Neurology 1997; 41: 402-4.
29. Gambardella A, Aguglia U, Chifari R, Labate A, Manna I, Serra P, Romeo N, Sibilia G, Lepiane E, Russa AL, Ventura P, Cittadella R, Sasanelli F, Colosimo E, Leggio U, Zappia M, Quattrone A. ApoEε4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy. Epilepsia 2005; 46: 110-7.